Company intelligence / Profile preview

CellmatiQ

Hamburg, Hamburg, Germanycellmatiq.com ↗

Ownership: Private
Development stage: Commercial

Overview

CellmatiQ has developed DentaliQ, an AI-powered software that automates the identification of diagnostic points in dental x-rays. This reduces analysis time from approximately 15 minutes to seconds while maintaining consistent quality. The product is commercially available and more products are reportedly in development[4].

Therapeutic areas: OtherOncology
Modalities: Non-pharmacological therapyDeviceSoftware (AI-based diagnostic tool)
Industry: Medical Imaging

Beyond the preview

Go deeper on CellmatiQ.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CellmatiQ.

Explore the full profile